Read the full publication here: #WeightManagement #ObesityMedicine #WeightLoss #Metabolic #GLP1 #Biotech To view or add a comment, sign in At TIXiMED, we are excited to share new peer-reviewed data on #TIX100, published in Diabetes, Obesity and Metabolism by investigators at the UAB Comprehensive Diabetes Center
The published trial data reflects ideal conditions (free medication, close monitoring, motivated participants)
The analysis used data from more than two million diabetes patients in the United States, including about 216,000 taking the popular drugs, to map out their risks and benefits across 175 possible health outcomes
"FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List." April 30, 2026
however, those experiencing significant losses may benefit from adding a small amount of salt to meals or consuming broth-based soups Magnesium : Nuts, seeds, whole grains, leafy green vegetables, and legumes Calcium : Dairy products, fortified plant-based alternatives, leafy greens, and tinned fish with bones Patients following very low-calorie diets should discuss nutritional supplementation with their healthcare provider or a registered dietitian
Environment Green-Score not computed Missing a precise category We could not compute the Green-Score of this product as it is missing some data, could you help complete it